1.Cas No: 111-44-4
2.Molecular formula: C4H8Cl2O
4.Melting point : −47 °C(lit.)
5.Boiling point: 65-67 °C15 mm Hg(lit.)
6.Density: 1.22 g/mL at 25 °C(lit.)
7.Refractive index: n20/D 1.456(lit.)
8.Storage conditions: 2-8°C
Application: 2,2′-Dichlorodiethyl Ether is used as a solvent for rubber, resin, etc., as a solvent for gas chromatography, as a solvent and dry cleaning agent for fats, paraffins, oils, etc., with stable properties, used as fats, oils, waxes, rubber, tar, asphalt, resin, ethyl
Solvents for fibers and pesticides for soil.
It is also used in organic synthesis and coatings.
Category: Other oxygenated compounds; organic building blocks; organic raw materials; general reagents; ethers; industrial raw materials; Building Blocks; C2toC8; Chemical Synthesis; Ethers; Organic Building Blocks; Oxygen Compounds; finechemical; finechemicalChemicalbooks; Quinoxalines, Quinazolines; intermediates; organic chemical raw materials; chemical raw materials.
We are Princechem Pharmaceutical manufacturer pass 20 years experience. Types of chemical reactions in are etherification, ammoniation, chlorination, esterification, cyclization, hydrogenation and Grignard reaction, etc..Over the past 10 years, more than 400 catalog products were developed. In recent years, more than 40 kinds of key pharmaceutical intermediates have been developed, involving anti-cancer, cardiovascular, digestive system, mental diseases and other fields. It includes the key intermediates of API such as Quetiapine, Fluvaxamine, Erlotinib, Gefitinib, Sunitinib, Lapatinib, Rabeprazole and Lafutidine. For many years, we have been providing high quality pharmaceutical intermediates for many world-famous pharmaceutical companies.
HI-Tech Enterprise was honored to YPC in 2011. The company adheres to scientific and technological innovation and has more than 10 authorized invention patents.
YPC insists on using the international standard management systems to promote our managements and have established the systems of ISO9001:2000, ISO14001:2004 and OHS18001:1999. Over the past few years, it has passed on-site audits by more than 20 international and domestic pharmaceutical companies.